Elsevier

Pathology

Volume 45, Issue 1, January 2013, Pages 44-48
Pathology

A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit

https://doi.org/10.1097/PAT.0b013e32835bc848Get rights and content

Summary

Aims

Cytological diagnosis of malignant pleural mesothelioma (MPM) is controversial, but has been used in our institution for over 30 years. To assess the role of effusion cytology in mesothelioma diagnosis we conducted an audit of pleural fluid cytology results over a 20 year period (1988–2007).

Methods

Pleural samples were received from 6285 patients; data linkage with Western Australian Cancer and Mesothelioma Registries demonstrated that 815 of these patients had a diagnosis of MPM. Cytological examination of a pleural effusion specimen had been performed in 517 (63%) of these 815 patients.

Results

Definitive cytological diagnosis of MPM was made in 377/517 cases, resulting in an ‘absolute’ sensitivity of 73%. An additional 66 patients were diagnosed as atypical/suspicious, resulting in a ‘complete’ sensitivity of 86%. If only biopsy/necropsy proven cases are considered, the absolute sensitivity is 68% and the complete sensitivity is 82%. There were no false positive diagnoses of malignancy; two patients with metastatic adenocarcinoma were initially diagnosed as MPM, prior to the availability of specific mesothelial markers, resulting in a positive predictive value of 99%.

Conclusions

Effusion cytology is an inexpensive, minimally invasive procedure which should be included in the diagnostic work-up of cases of suspected MPM.

References (37)

  • A. Churg et al.

    The separation of benign and malignant mesothelial proliferations

    Am J Surg Pathol

    (2000)
  • A.N. Husain et al.

    Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group

    Arch Pathol Lab Med

    (2009)
  • C. Boutin et al.

    Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis

    Cancer

    (1993)
  • R.L. Attanoos et al.

    The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma

    Histopathology

    (2008)
  • H.E. Davies et al.

    Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues

    Curr Opin Pulm Med

    (2008)
  • J. Leigh et al.

    Malignant mesothelioma in Australia, 1945–2002

    Int J Occup Environ Health

    (2003)
  • D. Whitaker

    The cytology of malignant mesothelioma

    Cytopathology

    (2000)
  • College of American Pathologists Committee on Nomenclature and Classification of Disease

  • Cited by (106)

    • The cytologic diagnosis of mesothelioma: are we there yet?

      2023, Journal of the American Society of Cytopathology
    • Malignant and borderline mesothelial tumors of the pleura

      2022, Practical Pulmonary Pathology: A Diagnostic Approach
    • Medical Thoracoscopy

      2021, Clinics in Chest Medicine
      Citation Excerpt :

      The diagnosis is generally considered difficult if not impossible to make by PFA-derived cytology; pleural biopsies are usually required. Sensitivity for MPM via PFA varies widely.4,53 Data suggest that pleural fluid cytology has poor sensitivity for diagnosing MPM (20%–51%).12,54,55

    • The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis

      2021, Pathology
      Citation Excerpt :

      Many patients present with recurrent pleural effusions, and there is the possibility of diagnosis of MM with an epithelioid component by cytology in isolation, which is embraced by some groups but regarded more cautiously or rejected by others.4,6–8 However, there are ample data to indicate that in skilled hands, cytological diagnosis of MM is reliable.9,10 In addition to these difficulties, benign asbestos related effusions are recognised.

    • Pleural Effusions: Overview and Diagnostic Approach

      2021, Encyclopedia of Respiratory Medicine, Second Edition
    View all citing articles on Scopus
    View full text